Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2010
11/17/2010EP2251033A1 Pharmaceutical formulations comprising paraoxonase
11/17/2010EP2251026A1 Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
11/17/2010EP2250166A1 Substituted piperidines as renin inhibitors
11/17/2010EP2250164A2 Angiotensin ii receptor blocker derivatives
11/17/2010EP2250158A2 Angiotensin ii receptor antagonists
11/17/2010EP2249841A1 Treating hypertension with 25-hydroxyvitamin d3
11/17/2010EP2249837A1 Methods of treating thromboembolic disorders
11/17/2010EP2249821A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs
11/17/2010EP2249819A1 Phytol as a cholesterol lowering agent
11/17/2010EP1931680B1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
11/17/2010EP1585522B1 Quinazolinones as potassium channel modulators
11/17/2010EP1032377B1 Substituted 2-aminoacetamides and the use thereof
11/17/2010CN1762410B Chinese dodder seed extract, its preparation method, Chinese proprietary medicine containing extracts thereof and use thereof
11/17/2010CN101889007A Method for amplifying hematopoietic stem cells using heterocyclic compound
11/17/2010CN101889004A Inhibitors of protein kinases
11/17/2010CN101886066A Treatment effect of tissue plasminogen activator kringle-2 on stroke and preparation method for tissue plasminogen activator kringle-2
11/17/2010CN101885731A Thiophene derivative
11/17/2010CN101885684A Aromatic acid pro-drug with nitrogen monoxide donor, and preparation method and application thereof
11/17/2010CN101884780A Use of hepcidin as a regulator of iron homeostasis
11/17/2010CN101884767A Plant extract composite for preventing diabetes complication and senium and preparation method thereof
11/17/2010CN101884766A Healthcare product or medicine for preventing diabetes complication and senium and preparation method thereof
11/17/2010CN101884765A Medicament for treating big belly known as beer belly
11/17/2010CN101884758A Food therapy preparation for preventing and treating cerebrovascular diseases based on theories of preventive treatment of disease and medicine food homology
11/17/2010CN101884737A Chinese medicinal composition for treating hemiparalysis
11/17/2010CN101884736A Medicinal composition for treating hypertension left ventricular hypertrophy and preparation method thereof
11/17/2010CN101884689A External medicament for treating piles
11/17/2010CN101884683A Uncaria slow-release pill preparation and preparation method thereof
11/17/2010CN101884679A Food therapy preparation for preventing and treating cardiovascular diseases based on theories of preventive treatment of disease and medicine food homology
11/17/2010CN101884674A Chinese medicament for preventing and treating hypertension
11/17/2010CN101884673A Piles ointment and preparation method thereof
11/17/2010CN101884667A Xiangdan medicament injection preparation containing polyethylene glycol 12-hydroxystearate and preparation method thereof
11/17/2010CN101884666A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof
11/17/2010CN101884662A Food therapy preparation for preventing and treating hypertension based on theories of preventive treatment of disease and medicine food homology
11/17/2010CN101884661A Traditional Chinese medical preparation containing leeches and astragalus and used for treating cardiovascular and cerebrovascular diseases
11/17/2010CN101884660A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof
11/17/2010CN101884656A Traditional Chinese medical composition, preparation method thereof and use thereof
11/17/2010CN101884655A Method for preparing pseudo-ginseng flower extract
11/17/2010CN101884638A Application of 5alpha-androstane-3beta,5,6beta-triol in preparing neuro-protective medicaments
11/17/2010CN101884637A Medicinal composition for treating cardiovascular diseases and application thereof
11/17/2010CN101884634A Composition for treating cardiovascular diseases
11/17/2010CN101884617A Method for preparing proanthocyanidins liposomes
11/17/2010CN101884614A Preparation of brain targeting chuanxiongzine oral oil package oil nano-emulsion
11/17/2010CN101884280A Method for planting selenium-enriched food for preventing diseases and resisting cancer
11/17/2010CN101361740B Pharmacy use of 2,5- bis (hydroxymethyl)-3,6-dimethyl pyrazine and derivates thereof
11/17/2010CN101342326B Preparation method for traditional Chinese medicine for treating fire excess from Yin deficiency type nodal tachyeardia
11/17/2010CN101310733B Medicine composition for treating the cerebrovascular disease and preparation method thereof
11/17/2010CN101224205B Composition of atorvastatin and levorotatory amlodipine and preparing method thereof
11/17/2010CN101199511B Andrographis lactone self-emulsification capsule of antibacterial antiphlogistic
11/17/2010CN101129498B New use of tree peony oil in decreasing blood sugar and slimming
11/17/2010CN101073666B Method for producing kallidin proenzyme raw-material medicine
11/17/2010CN101062027B Taurine and medical combination for treating cardiovascular and cerebrovascular diseases
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834178 Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
11/16/2010US7834060 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834033 administering a tumor necrosis factor inhibitor; angiogenesis inhibitor; treating inflammatory, and autoimmune diseases
11/16/2010US7834020 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia
11/16/2010US7834006 antidiabetics; lower blood glucose levels; compounds based on 1H,2H,3H,4H,5H,6H,7H,8H-pyrrolo[3,4-e][1,4]diazepin-6-one
11/16/2010US7833993 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia
11/16/2010US7833990 accelerating vascular endothelial repair with a low haemorrhage risk in the event of thrombotic injuries; promoting revascularization in ischemic tissues and vascular modelling in thrombotic injuries; produced by the marine bacterium Alteromonas
11/16/2010US7833972 Proteins and use thereof
11/16/2010US7833742 Fabry disease; X-linked inherited lysosomal storage disease characterized by severe renal impairment, angiokeratomas, and/or cardiovascular abnormalities; selecting a human alpha -Gal A preparation having a desired pharmacokinetic parameter
11/16/2010US7833697 Endothelial stem cells, populations, methods of isolation and use thereof
11/16/2010US7833546 Pharmaceutical dosage form and method for the production thereof
11/16/2010US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them
11/16/2010CA2622452C Hemodynamics improving agent
11/16/2010CA2479084C Vdac regulator
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
11/16/2010CA2471220C Novel alkansulfonamides as endothelin antagonists
11/16/2010CA2455223C Crfr1 selective ligands
11/16/2010CA2427548C Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/16/2010CA2416535C Non-sedating barbiturate compounds as neuroprotective agents
11/16/2010CA2415643C Pharmaceutical composition for oral use with improved absorption
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/16/2010CA2367240C Treatment of accidental extravasation of anthracyclines
11/16/2010CA2337361C Targeted site specific drug delivery compositions and method of use
11/11/2010WO2010129964A1 Drug targets for prevention of arrhythmia in heart disease
11/11/2010WO2010129670A2 Method for modulating angiogenesis using fibromodulin
11/11/2010WO2010129655A2 Natriuretic polypeptides having mutations within their disulfide rings
11/11/2010WO2010129467A1 Compounds and methods for inhibition of renin, and indications therefor
11/11/2010WO2010128672A1 Neovascularization inducer comprising genetically recombined gelatin
11/11/2010WO2010128401A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
11/11/2010WO2010127642A1 Antibodies that recognize sulphatides and sulphated proteoglycans and the use thereof
11/11/2010WO2010127381A1 Diagnosis, monitoring, prognosis, prevention and treatment of aneurysms
11/11/2010WO2010092015A8 Urea triazolo [1, 5-a] pyridine derivatives as pi3k inhibitors
11/11/2010WO2010042886A3 Pyrones for the treatment of metabolic disorders
11/11/2010WO2009152052A8 Methods of treating alpha adrenergic mediated conditions
11/11/2010WO2009135581A9 Nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
11/11/2010US20100286762 Compositions and Methods for Ameliorating Clinical Electrical Disturbances
11/11/2010US20100286589 Atherosclerotic Plaque Dissolution Composition
11/11/2010US20100286375 Carrier molecules
11/11/2010US20100286276 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof
11/11/2010US20100286275 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
11/11/2010US20100286269 Medium-Chain Length Fatty Acids and Glycerides as Nephroprotection Agents
11/11/2010US20100286267 Compounds for the treatment of metabolic disorders
11/11/2010US20100286255 Method for extracting secoisolariciresinol and dihydroquercetin from wood
11/11/2010US20100286253 Method for treating ocular neovascularization
11/11/2010US20100286247 Methods of Protection from Oxidative Stress
11/11/2010US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
11/11/2010US20100286225 Diazeniumdiolate compounds, a process for their preparation and pharmaceutical compositions containing them.